Evaluation of central serotonin sensitivity in breast cancer survivors with cancer-related fatigue syndrome

Journal of Pain and Symptom Management

Volumn 40, Issue 6, 2010, Pages 892-898

  Alexander, Susanna ^a   Stone, Patrick ^a   White, Sarah ^a   Andrews, Paul ^a   Nussey, Stephen ^a   Bano, Gul ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Breast neoplasms; Buspirone; Fatigue; Hydrocortisone; Prolactin; Serotonin

Indexed keywords

BUSPIRONE; HYDROCORTISONE; PROLACTIN;

ARTICLE; BREAST CANCER; CANCER FATIGUE; CANCER SURVIVOR; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EARLY CANCER; FEMALE; HUMAN; HYDROCORTISONE RELEASE; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; STRUCTURED INTERVIEW;

AREA UNDER CURVE; BREAST NEOPLASMS; BUSPIRONE; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; HUMANS; HYDROCORTISONE; PROLACTIN; SEROTONIN; SEROTONIN RECEPTOR AGONISTS; SURVIVORS;

EID: 78649952094     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2010.03.023     Document Type: Article

References (24)

1. P.C. Stone, and O. Minton Cancer-related fatigue Eur J Cancer 44 2008 1097 1104
2. O. Minton, and P. Stone How common is fatigue in disease-free breast cancer survivors? A systematic review of the literature Breast Cancer Res Treat 112 2008 5 13
3. D. Cella, A. Peterman, S. Passik, P. Jacobsen, and W. Breitbart Progress toward guidelines for the management of fatigue Oncology (Williston Park) 12 1998 369 377
4. S. Alexander, O. Minton, P. Andrews, and P. Stone A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome Eur J Cancer 45 2009 384 392
5. G.R. Morrow, P.L.R. Andrews, J.T. Hickok, J.A. Roscoe, and S. Matteson Fatigue associated with cancer and its treatment Support Care Cancer 10 2002 389 398
6. J.E. Bower Cancer-related fatigue: links with inflammation in cancer patients and survivors Brain Behav Immun 21 2007 863 871
7. A. Jager, S. Sleijfer, and C.C.D. van der Rijt The pathogenesis of cancer related fatigue: could increased activity of pro-inflammatory cytokines be the common denominator? Eur J Cancer 44 2008 175 181
8. A.A.B. Badawy, C.J. Morgan, M.B. Llewelyn, S.R.J. Albuquerque, and A. Farmer Heterogeneity of serum tryptophan concentration and availability to the brain in patients with the chronic fatigue syndrome J Psychopharmacol 19 2005 385 391
9. L.M. Castell, T. Yamamoto, J. Phoenix, and E.A. Newsholme The role of tryptophan in fatigue in different conditions of stress Adv Exp Med Biol 467 1999 697 704
10. A.M. Bakheit, P.O. Behan, T.G. Dinan, C.E. Gray, and V. O'Keane Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome BMJ 304 1992 1010 1012
11. M. Sharpe, A. Clements, and K. Hawton Increased prolactin response to buspirone in chronic fatigue syndrome J Affect Disord 41 1996 71 76
12. M. Sharpe, K. Hawton, A. Clements, and P.J. Cowen Increased brain serotonin function in men with chronic fatigue syndrome BMJ 315 1997 164 165
13. R. Depoortere, D. Boulay, and G. Perrault SSR181507, a dopamine D2 receptor antagonist and 5-HT1A receptor agonist. II: behavioral profile predictive of an atypical antipsychotic activity Neuropsychopharmacology 28 2003 1889 1902
14. M. Spitzer, M. Gibbon, and J. Williams Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, non-patient edition (SCID-I/NP) 2002 New York State Psychiatric Institute New York
15. M.W. Bridge, G. Marvin, and C.E. Thompson Quantifying the 5-HT1A agonist action of buspirone in man Psychopharmacology 158 2001 224 229
16. D.G. Altman Serial measurements - the area under the curve D.G. Altman, Practical statistics for medical research 1999 Chapman & Hall/CRC Boca Raton, FL
17. J.L. Ryan, J.K. Carroll, and E.P. Ryan Mechanisms of cancer-related fatigue Oncologist 12 Suppl 1 2007 22 34
18. E. Blomstrand, P. Hassmen, B. Ekblom, and E.A. Newsholme Administration of branched-chain amino acids during sustained exercise - effects on performance and on plasma concentration of some amino acids Eur J Appl Physiol 63 1991 83 88
19. K.D. Mittleman, M.R. Ricci, and S.P. Bailey Branched-chain amino acids prolong exercise during heat stress in men and women Med Sci Sports Exerc 30 1998 83 91
20. H.K. Struder, W. Hollmann, and P. Platen Influence of paroxetine, branched-chain amino acids and tyrosine on neuroendocrine system responses and fatigue in humans Horm Metab Res 30 1998 188 194
21. W.M. Wilson, and R.J. Maughan Evidence for a possible role of 5-hydroxytryptamine in the genesis of fatigue in man: administration of paroxetine, a 5-HT re-uptake inhibitor, reduces the capacity to perform prolonged exercise Exp Physiol 77 1992 921 924
22. G.R. Morrow, J.T. Hickok, and J.A. Roscoe Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program J Clin Oncol 21 2003 4635 4641
23. M.J.H. Kenter, and A.F. Cohen Establishing risk of human experimentation with drugs: lessons from TGN1412 Lancet 368 2006 1387 1391
24. E.A. Malt, S. Olafsson, and A. Aakvaag Altered dopamine function in fibromyalgia patients: a neuroendocrine study with buspirone in women with fibromyalgia compared to female population based controls J Affect Disord 75 2003 77 82